Clinical Trials Browser

Withdrawn × Multiple Myeloma × Blood Specimen Collection × Clear all

NCT04150692 2022-01-24

Escalation of Daratumumab Frequency Following Biochemical Progression in Relapsed/Refractory Multiple Myeloma

Phase 2 Withdrawn

Multiple Myeloma